Leaflet: information for the user
Risperidone cinfa 1 mg/ml oral solution EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Risperidone cinfa belongs to a group of medicines called “antipsychotics”.
Risperidone cinfa is used to treat the following:
Risperidone may help reduce the symptoms of your illness and prevent them from coming back.
Do not take risperidone cinfa
If you are unsure, consult your doctor or pharmacist before starting to take risperidone.
Warnings and precautions
Consult your doctor or pharmacist before starting to take risperidone cinfa.
If you are unsure about whether the above information affects you, consult your doctor or pharmacist before taking risperidone.
Because in very rare cases, a dangerously low number of a type of white blood cell necessary to fight infections in the blood has been observed in patients treated with risperidone, your doctor may check your white blood cell count.
Risperidone may cause you to gain weight. A significant weight gain may affect your health unfavourably. Your doctor will regularly monitor your weight.
Because diabetes mellitus or worsening of pre-existing diabetes mellitus has been seen in patients taking risperidone, your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
Risperidone frequently increases the levels of a hormone called prolactin. This may cause adverse effects such as menstrual disorders or fertility problems in women or breast swelling in men (see Possible side effects). If these adverse effects appear, it is recommended that blood prolactin levels be evaluated.
During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the coloured part of the eye) may become flaccid during surgery and this may cause eye damage. If you are planning to have eye surgery, make sure to inform your ophthalmologist that you are taking this medicine.
Patients with advanced age and dementia
In patients with advanced age and dementia, there is an increased risk of having a stroke. You should not take risperidone if you have dementia caused by a stroke.
You should see your doctor regularly during treatment with risperidone.
If you or your caregiver notice a sudden change in your mental state or the sudden appearance of weakness or numbness in the face, arms or legs, especially on one side, or if you speak confusedly, even for a short time, seek immediate medical treatment. This may be a sign of a stroke.
Children and adolescents
Other causes of aggressive behaviour should be ruled out before starting treatment for conduct disorders.
If during treatment with risperidone you experience fatigue, changing the administration times may improve your difficulties with attention.
Before starting treatment, your weight or that of your child may be measured and regularly monitored during treatment.
A small, inconclusive study has reported an increase in the height of children who took risperidone, but it is unknown whether this is a side effect of the drug or due to another reason.
Other medicines and risperidone cinfa
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.
It is especially important to talk to your doctor or pharmacist if you are taking any of the following
The following medicines may reduce the effect of risperidone:
If you start or stop taking these medicines, you may need a different dose of risperidone.
The following medicines may increase the effect of risperidone:
If you start or stop taking these medicines, you may need a different dose of risperidone.
If you are unsure about whether the above information affects you, consult your doctor or pharmacist before taking risperidone.
Taking risperidone cinfa with food, drink and alcohol
You can take this medicine with or without food. You should avoid consuming alcohol while taking risperidone.
Risperidone oral solution should not be mixed with tea.
Pregnancy, breastfeeding and fertility
Driving and operating machinery
Risperidone may cause symptoms such as drowsiness, dizziness or visual disturbances, and may decrease your reaction time. These effects, as well as the underlying condition, may make it difficult for you to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention, until your doctor assesses your response to this medicine.
Risperidone cinfa contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per ml; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is as follows:
For the treatment of schizophrenia
Adults
Older adults
For the treatment of mania:
Adults
Older adults
For the treatment of long-term aggression in people with Alzheimer's disease:
Adults (including older adults)
Use in children and adolescents
The dose will depend on your child's weight for the treatment of behavioral disorders:
If your child weighs less than 50 kg
If your child weighs 50 kg or more
The duration of treatment in patients with behavioral disorders should not exceed 6 weeks
Children under 5 years old should not receive risperidone for behavioral disorders
Patients with liver or kidney problems
Unless the disease being treated is taken into account, all initial doses and subsequent doses of risperidone should be reduced by half. Dose increases should be made more slowly in these patients. Risperidone should be used with caution in this group of patients
How to take risperidone cinfa:
Oral administration
Risperidone oral solution
The solution comes with a syringe (pipette). Use only the syringe (pipette) provided with this medication to measure the prescribed dose. Measure the exact amount of medication you need. Be careful when measuring a small dose, for example, for 0.25 mg it is precise to measure 0.25 ml (a quarter of a milliliter); for 0.5 mg it is precise to measure 0.5 ml (half a milliliter)
Follow these steps:
If you take more risperidone cinfa than you should
If you forget to take risperidone cinfa
If you interrupt the treatment with risperidone cinfa
Do not stop taking this medication unless your doctor tells you to. Symptoms may reappear. If your doctor decides to stop treatment, your dose may be gradually reduced over a few days
If you have any other questions about using this medication, ask your doctor or pharmacist
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 100 patients):
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 1,000 patients):
The following side effects may also occur:
Very common (may affect more than 1 in 10 patients):
Common (may affect up to 1 in 10 patients):
Rare (may affect up to 1 in 100 patients):
Rare (may affect up to 1 in 1,000 patients):
Very rare (may affect up to 1 in 10,000 patients):
The following side effect has occurred with the use of another medication called paliperidone, which is very similar to risperidone, so it is also expected to occur with risperidone: rapid heartbeat when standing up.
Other side effects in children and adolescents
In general, it is expected that side effects in children will be similar to those that occurred in adults. The following side effects were reported more frequently in children and adolescents (5 to 17 years) than in adults: feeling drowsy or less alert, fatigue (tiredness), headache, increased appetite, vomiting, common cold symptoms, nasal congestion, abdominal pain, dizziness, cough, fever, tremor (shaking), diarrhea, and urinary incontinence.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Store below 30 °C. Do not freeze. Store in the original packaging.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Once the bottle is opened, unused portions should be discarded after 3 months.
Medications should not be disposed of through drains or trash. Deposit containers and unused medications at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and unused medications. By doing so, you will help protect the environment.
Composition of risperidone cinfa
Appearance of the product and contents of the container:
Risperidone cinfa is a transparent and colorless, slightly yellowish solution with a lemon odor. It is presented in amber glass bottles with a child-resistant plastic closure of 30 or 100 ml with a 3 ml calibrated dosing syringe. The minimum volume is 0.25 ml. The maximum volume is 3 ml.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Cinfa Laboratories, S.A.
Olaz-Chipi Road, 10 - Areta Industrial Estate.
31620 Huarte (Navarra) - Spain
Responsible for manufacturing
MEIJI PHARMA SPAIN, S.A.
Madrid Avenue, 94
28802 Alcalá de Henares (Madrid)
Spain
or
MEDINFAR MANUFACTURING, S.A.
Armando Martins Tavares Industrial Park
Rua Outeiro Da Armada, 5
Condeixa-a-Nova, 3150-194, Sebal
Portugal
Last review date of this leaflet:March 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS).http://www.aemps.gob.es/
You can access detailed and updated information about this medication by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/70047/P_70047.html
QR code to:https://cima.aemps.es/cima/dochtml/p/70047/P_70047.html
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.